Overcoming the hurdles to achieving glycemic control
Author:
- 31 May 2006
- journal article
- Published by Elsevier in Metabolism
- Vol. 55, S6-S9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Secondary sulfonylurea failure: Comparison of period until insulin treatment between diabetic patients treated with gliclazide and glibenclamideDiabetes Research and Clinical Practice, 2005
- Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative studyBMJ, 2005
- Barriers to concordance with antidiabetic drugs—cultural differences or human nature?BMJ, 2005
- Gliclazide protects pancreatic β-cells from damage by hydrogen peroxideBiochemical and Biophysical Research Communications, 2003
- Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practiceDiabetes & Metabolism, 2003
- Effective diabetes care: a need for realistic targetsBMJ, 2002
- Gliclazide modified release: From once-daily administration to 24-hour blood glucose controlMetabolism, 2000
- Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)JAMA, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study GroupDiabetes, 1995